Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain—A retrospective observational real‐world study

BACKGROUND: Cannabinoids are considered a therapeutic option to patients suffering from treatment refractory chronic pain (TRCP) insufficiently relieved by conventional analgesics or experiencing intolerable adverse events (AEs) from those. This study aimed to explore safety and effectiveness of ora...

Descripción completa

Detalles Bibliográficos
Autores principales: Horsted, Tina, Hesthaven, Karoline Lichon, Leutscher, Peter Derek Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107230/
https://www.ncbi.nlm.nih.gov/pubmed/36394124
http://dx.doi.org/10.1002/ejp.2054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107230/
https://www.ncbi.nlm.nih.gov/pubmed/36394124
http://dx.doi.org/10.1002/ejp.2054

Ejemplares similares